Interferences - are some methods better than others? Graham Jones Department of Chemical Pathology St Vincent’s Hospital, Sydney.

Slides:



Advertisements
Similar presentations
So how good are your results? (An introduction to quantitative QC)
Advertisements

AACB NSW/ACT QC Subcommittee TnT hs Survey Results Methods Results Introduction Persephone Giannopoulos¹ and representatives of the AACB NSW/ACT QC Subcommittee.
Calibration methods Chemistry 243.
ERRORS IN THE LABORATORY Dr Joe Fleming PhD. MCB, FRCPath CMC Vellore.
World Health Organization
L MACKAY, N CRINIS, Q LAM, R SCOTT
MHA APCCB A SERUM INDEX FOR METHAEMALBUMIN: THE M-INDEX GRD Jones, M Roser, B Zworestine Department of Chemical Pathology, St Vincents Hospital,
Limitations of Analytical Methods l The function of the analyst is to obtain a result as near to the true value as possible by the correct application.
Quality Assurance.
LABORATORY QUALITY CONTROL
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
Quality Assessment Lecture 2.
Quality Assurance in the clinical laboratory
BOHB APCCB LABORATORY USE OF THE ABBOTT MEDISENSE METER FOR BETA-HYDROXYBUTYRATE MEASUREMENT. GRD Jones, A Screnci, P Graham Chemical Pathology,
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Chemometrics Method comparison
Quality Assurance.
Quality Assessment 2 Quality Control.
APCCB AVERAGE OF DELTA – A NEW CONCEPT IN QUALITY CONTROL GRD Jones Department of Chemical Pathology, St Vincents Hospital, Sydney, Australia.
Method Selection and Evaluation Method Selection and Evaluation D. Kefaya EL- Sayed Mohamed Prof. Of Clinical Pathology (Clinical Chemistry), Mansoura.
ABC of Quality Control A problem based approach RT ERASMUS NHLS / FACULTY OF HEALTH SCIENCES, UNIVERSITY OF STELLENBOSCH 20th July, 2007, Bela Bela.
AACB ASM 2003 THE POWER OF ERROR DETECTION OF WESTGARD MULTI-RULES: A RE-EVALUATION Graham Jones Department of Chemical Pathology St Vincent’s Hospital,
The following minimum specified ranges should be considered: Drug substance or a finished (drug) product 80 to 120 % of the test concentration Content.
QUALITY ASSURANCE Reference Intervals Lecture 4. Normal range or Reference interval The term ‘normal range’ is commonly used when referring to the range.
Evaluation of Beckton-Dickinson PST II and SST II Blood Collection Tubes P Graham, B Martin, M Roser, G Jones Department of Chemical Pathology, St Vincent’s.
Quality WHAT IS QUALITY
Biostatistics: Measures of Central Tendency and Variance in Medical Laboratory Settings Module 5 1.
BY : Dr. Beenish Zaki, Instructor Department of Biochemistry (15 February 2012)
Chapter 5 Errors In Chemical Analyses Mean, arithmetic mean, and average (x) are synonyms for the quantity obtained by dividing the sum of replicate measurements.
Quality Control Lecture 5
Stability APACB MATRIX AND STABILITY STUDY: PTH, INSULIN AND C-PEPTIDE Boscato L, Bayoun R and Jones GRD Chemical Pathology, St Vincent’s Hospital,
4 WELCOME. 4 Two Significant Stats 70 % 40%
G Jones, M Roser Department of Chemical Pathology
BNPCV APCCB BIOLOGICAL VARIATION FOR N-TERMINAL PRO-BNP Jones GRD 1, Bennett A 2,3, Boscato L 1, Macdonald P 2, Brien J 3. Departments of Chemical.
Prof. Dr.Asim Mumtaz Shalamar Medical & Dental College Lahore Effect of Lab Errors on Patient Care.
Quality Assurance How do you know your results are correct? How confident are you?
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Graham Jones Department of Chemical Pathology,
Blood tubes. Using the appropriate phlebotomy supplies is imperative for accurate test results. Each vacutainer tube is color-coded to facilitate proper.
Verification of qualitative methods
Solutions used in medical laboratory. O Solution is a homogeneous mixture of two or more substances. O Solute is the dissolved substance, whereas solvent.
Comparability of methods and analysers Nora Nikolac
QC/QA.
Quality Control Internal QC External QC. -Monitors a test's method precision and analytical bias. -Preparation of quality control samples and their interpretation.
L ABORATORY Q UALITY C ONTROL. INTRODUCTION _A major role of the clinical laboratory is the measurement of substances in body fluids or tissues for the.
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
Pre- analytic Analytic Post- analytic  S pecimen collection  Specimen transport  Specimen quality  Result accuracy  Clerical.
By: EID ALATAWI Serial Dilution. Introduction: Many of the laboratory procedures involve the use of dilutions. It is important to understand the concept.
Result Authorisation – Correct or Not? Julie RYAN FAACB Chair SRAC AACB Healthscope Pathology.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
Quality Assessment.
Solutions used in medical laboratory
Introduction to Lab Quality
Pakistan Society Of Chemical Pathologists Zoom Series of Lectures ZT 24. Quality Managent 1 Brig Aamir Ijaz MCPS, FCPS, FRCP (Edin), MCPS-HPE HOD and.
Quality Assurance in the clinical laboratory
MARK RIDGWELL, DIASUKE TANAKA & CCG WOOD Within run Imprecision
P.J. Showell1, E.A. Lynch1, H.D. Carr-Smith1, A.R. Bradwell2
Chapter 8: Inference for Proportions
Practical clinical chemistry
به نام خدا تضمين کيفيت در آزمايشگاه
Shaimah Al-Failakawi Al Amiri Hospital Laboratory Quality Manager
Choice of Methods and Instruments
Quality Assurance 1 Lecture 2.
USE OF CLINICAL LABORATORY
Method Selection and Evaluation
Introduction To Medical Technology
Quality Control Lecture 3
▪Internal quality control:
USE OF CLINICAL LABORATORY
Reporting of critical potassium results reporting in hyperkalaemia: Audit and survey of practice in Scotland Neil Greig 24/04/17.
Presentation transcript:

Interferences - are some methods better than others? Graham Jones Department of Chemical Pathology St Vincent’s Hospital, Sydney

Contents  Background  Choosing your instrument  Using your instrument

Introduction  Our aim: to produce timely, accurate results to allow optimal patient care  Interferences - substances present in a sample, or events affecting a sample, which lead to the production of inaccurate results  Accuracy: results which reflect the result which would have been obtained if the interference had not been present

Interference Importance  May lead to a clinical error  Wrong management with bad outcome  Interference-related clinical errors quite rare  Most clinical errors require several mishaps concurrently  Many “near misses”  BUT: can cost time, additional testing, reduced doctor confidence

Error Importance  Erroneous and Non-believable  eg potassium of 10.0 due to haemolysis or EDTA contamination  Result: ignore or recollect specimen  Erroneous and Believable  eg potassium of 5.5 due to haemolysis or EDTA contamination  result: unnecessarily cease potassium supplements

Common Interferences  In-vitro haemolysis  Bilirubin  Lipaemia  Drugs  Immunoglobulins  Events (eg delayed separation)  Other (artificial blood)

Common Interferences  In-vitro haemolysis  Bilirubin  Lipaemia  Drugs  Immunoglobulins  Events (eg delayed separation)  Other (artificial blood) The visible interferences

Given factors  We wish to have accurate results  We wish to avoid errors due to interferences  We aim to give out results when they are accurate  We aim to withhold results which are inaccurate  This implies different cutoff levels for different analytes

Choosing your instrument

Assesment of Interferents  Melvin Glick  Clin Chem (1987) 33:  Add known amounts of RBC lysate; Intralipid; bilirubin to normal serum  Standard procedures  Plot percent change in result vs interferent concentration  “Interferographs”

Interferographs: Glick Final/original result x 100 (%) Haemolysate added (as haemoglobin. mg/dL) 110% 90% * Bilirubin C.Bilirubin Glucose * Urea * Chloride * Creatinine GGT

Glick  Most work performed in 1980s  Work performed using his own blood (reliable supply, but limited quantity)  Limited comprehensive third party data available for current instruments  Data from our own studies  Haemolysis Interference in Modern Instruments Clin Biochem Revs 2000;21:124  Icterus Interference in Modern Instruments Clin Biochem Revs 2000;21:124

Interferogram Roche Modular Haemolysis Haemolysate added to patient samples and concentrations measured

Instruments

Comparing Interference Performance: Amylase and Haemolysis Haemoglobin (mg/dL) Using RCPA-AACB Allowable Limits of Performance

Instrument Comparison  Some Instruments are better than others but  All are affected by interferences  Data is NOT transferable between instruments  There is room for improvement by manufacturers

Effect of Haemolysis - methods Examples of tests where different instruments show wide variations in response to haemolysis (Data from 2000).

Method Comparison  Some methods better than others  Suggest choosing methods which are less prone to interference  May require third party supplier

Using your instrument

Using Your Instrument  Once the instrument is chosen the fun begins  A protocol must be set which allows appropriate response to samples with interferences  requires detailed knowledge of your method / instrument  Sources:  Manufacturer  Literature  Own studies

Olympus Cholesterol Reagent and Modular Cholesterol Reagent Olympus Results Modular Results

Olympus Results: 10% at , 4.1 and 6.0 mmol/L Modular Results 10% at mmol/L Response best expressed as absolute (not not percentage)

Data Sources  Best data is from your own instrument  No factors  Full data set  Perform experiment as needed.  Manufacturer information best when all results available  Beware of “No Interference” limits (eg 10%)  Format of limits may not be useful

How accurate do we need to be?  RCPA-AACB Quality Assurance limits  Change greater than 2 SD of analytical precision  Change related to biological variation  10%  Other fixed percentage or absolute values  A difference that may lead to a change in clinical management - subjective*

Error Budget Int. errorOther errors Total error

The Accuracy - Utility Balance More accuracy More rejections More recollections More delays Unhappier ptns and Drs Fewer clinical errors Less accuracy Fewer rejections Fewer recollections Shorter TAT More clinical errors

Interference Limits  No easy solution  Take all factors into account  Likely clinical effects is the main parameter  (personal opinion)  Include pathologist / clinician in decision making

SydPath Haemolysis Protocol

Other quality factors  Sample type:  Serum, heparin plasma, EDTA plasma, fluoride oxalate, Citrate, gel separators.  Sample stability  As whole blood, as serum/plasma  At RT, 4 degrees, -20 degrees

What can I do that will make a difference to your business? A supplier’s question…

Suppliers…..  Quality data on interferences, sample types and analyte stability can:  Reduce recollections  Reduce unnecessary recollections  Reduce repetition in multiple laboratories  Head office, literature watch, local data

Conclusions  Interferences and our response to them are part of providing a quality laboratory service  Choose methods and instruments with low interference  Choose methods where data is available about interferences or generate local data  Implement a policy for responding to interferences